CTMX earnings: a negative outcome, -8.8%

On November 6, 2018, CytomX Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -8.8% in the window around the event. It had already run -12.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.